Hospitalisation risk for COVID-19 patients infected with SARS-CoV-2 variant B.1.1.7: cohort analysis

@article{Nyberg2021HospitalisationRF,
  title={Hospitalisation risk for COVID-19 patients infected with SARS-CoV-2 variant B.1.1.7: cohort analysis},
  author={Tommy Nyberg and Katherine A Twohig and Ross J Harris and Shaun R Seaman and Joseph Flannagan and Hester Allen and Andr{\'e} Charlett and Daniela De Angelis and Gavin Dabrera and Anne M. Presanis Mrc Biostatistics Unit and University of Cambridge and Cambridge and United Kingdom. and COVID-19 National Epidemiology Cell and Public Health England and London and National Infection Service},
  journal={arXiv: Applications},
  year={2021}
}
Medical Research Council (Unit programme number MC_UU_00002/11, SRS Unit programme number MC_UU_00002/10); MRC UKRI/DHSC NIHR COVID-19 rapid response call (grant ref: MC_PC_19074). This research was also supported by the NIHR Cambridge Biomedical Research Centre. 
1 Citations

Figures and Tables from this paper

Rapid Global Spread of the SARS-CoV-2 Delta (B.1.617.2) Variant: Spatiotemporal Variation and Public Health Impact
TLDR
The Delta VOC has greater transmissibility and risk of hospitalization than the ancestral SARS-CoV-2 strains and the other three VOCs, and places partially or unvaccinated sub-populations at high risk.

References

SHOWING 1-10 OF 32 REFERENCES
Analysis of severe outcomes associated with the SARS-CoV-2 Variant of Concern 202012/01 in England using ICNARC Case Mix Programme and QResearch databases.
TLDR
A new, more transmissible variant of SARS-CoV-2, variant of concern (VOC) 202012/01, has emerged in the UK and appears to be more severe than previous variants, with patients with VOC B.1.1-1.7 at increased risk of critical care admission and mortality compared with patients without.
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England.
TLDR
It is found that changes in VOC frequency inferred from genetic data correspond closely to changes inferred by S-gene target failures (SGTF) in community-based diagnostic PCR testing and there is a consensus among all analyses that the VOC has a substantial transmission advantage with a 50% to 100% higher reproduction number.
Assessment of Mortality and Hospital Admissions Associated with Confirmed Infection with SARS-CoV-2 Variant of Concern VOC-202012/01 (B.1.1.7) a Matched Cohort and Time-to-Event Analysis
TLDR
Evidence of increased risk of hospitalisation is found after adjusting for key confounders, suggesting increase infection severity associated with this variant of SARS-CoV-2 variant VOC202012/01, suggesting more severe clinical outcomes compared to wild-type infection.
COVID-19 Hospitalizations, ICU Admissions and Deaths Associated with the New Variants of Concern
TLDR
Because the increased risk of COVID-19 hospitalization, ICU admission and death with VOCs is most pronounced 14 to 28 days after diagnosis, there will be significant delays until the full burden to the health care system becomes apparent.
Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England
TLDR
There is increased risk of death for VOC compared with non-VOC cases in England andabsolute risk ofDeath by 28-days increased with age and comorbidities.
Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 February
  • D. Grint, K. Wing, R. Eggo
  • Medicine
    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
  • 2021
TLDR
This work found increased risk of death for VOC compared with non-VOC cases in England and found Absolute risk ofDeath by 28 days increased with age and comorbidities.
Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021
  • T. Funk, A. Pharris, C. Adlhoch
  • Medicine
    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
  • 2021
TLDR
The authors compared 19,207 cases of SARS-CoV-2 variant B.1.7/S gene target failure, B.3/SGTF and P.11.1 to non-variant cases reported by seven European countries to find cases with these variants had significantly higher adjusted odds ratios for hospitalisation and intensive care admission.
Epidemiology of Confirmed COVID-19 Deaths in Adults, England, March–December 2020
Of the 58,186 coronavirus deaths among adults in England during March–December 2020, 77% occurred in hospitals, 93% were in patients >60 years, and 91% occurred within 28 days of positive specimen.
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
TLDR
The rapid spread of VOC 202012/01 suggests that it transmits more efficiently from person to person than preexisting variants of SARS-CoV-2, which could lead to global surges in COVID-19 hospitalizations and deaths, so there is an urgent need to estimate how much more quickly this variant spreads.
...
1
2
3
4
...